308 related articles for article (PubMed ID: 16000871)
21. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone.
Lappas M; Permezel M; Georgiou HM; Rice GE
J Clin Endocrinol Metab; 2002 Oct; 87(10):4667-72. PubMed ID: 12364456
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
23. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
24. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
Boyault S; Bianchi A; Moulin D; Morin S; Francois M; Netter P; Terlain B; Bordji K
FEBS Lett; 2004 Aug; 572(1-3):33-40. PubMed ID: 15304320
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Chen CW; Chang YH; Tsi CJ; Lin WW
J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
[TBL] [Abstract][Full Text] [Related]
27. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
Liu X; Yu H; Yang L; Li C; Li L
Eur J Cell Biol; 2012 Aug; 91(8):654-61. PubMed ID: 22560326
[TBL] [Abstract][Full Text] [Related]
28. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
29. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
30. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
[TBL] [Abstract][Full Text] [Related]
32. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
[TBL] [Abstract][Full Text] [Related]
33. 15-Deoxy-Δ(12,14)-prostaglandin J2 inhibits IL-13 production in T cells via an NF-κB-dependent mechanism.
Doyle MC; Tremblay S; Dumais N
Biochem Biophys Res Commun; 2013 Feb; 431(3):472-7. PubMed ID: 23333326
[TBL] [Abstract][Full Text] [Related]
34. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
[TBL] [Abstract][Full Text] [Related]
35. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P
J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914
[TBL] [Abstract][Full Text] [Related]
36. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
37. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J
Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507
[TBL] [Abstract][Full Text] [Related]
38. Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells.
Siavash H; Nikitakis NG; Sauk JJ
Br J Cancer; 2004 Sep; 91(6):1074-80. PubMed ID: 15316561
[TBL] [Abstract][Full Text] [Related]
39. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.
Raman P; Kaplan BL; Thompson JT; Vanden Heuvel JP; Kaminski NE
Mol Pharmacol; 2011 Jul; 80(1):201-9. PubMed ID: 21511917
[TBL] [Abstract][Full Text] [Related]
40. 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells.
Rajasingh J; Bright JJ
Exp Cell Res; 2006 Aug; 312(13):2538-46. PubMed ID: 16737695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]